Loading

DEA

  • by Paul Armentano, NORML Deputy Director April 22, 2015

    Michele LeonhartDrug Enforcement Administration head Michele Leonhart is stepping down, US Attorney General Eric Holder has confirmed.

    Members of the US House Oversight Committee gave Leonhart a vote of “no confidence” last week after an Office of the Inspector General report revealed that senior DEA officials had participated in sex parties arranged by Colombian drug cartels and had also received weapons and cash from cartel members. None of the agents involved were fired by director Leonhart.

    Michele Leonhart began serving as the agency’s acting director in November 2007 before being confirmed as DEA administrator in 2010.

    Leonhart had consistently taken a hardline stance against any change in marijuana policy. Early in her tenure she oversaw dozens of federal raids on medical marijuana providers and producers in states that had legalized the plant. She set aside a verdict from the agency’s own administrative law judge that sought to expand and facilitate clinical research into marijuana as a medicine and she rejected an administrative petition calling for marijuana rescheduling hearings. She openly criticized remarks made by the President acknowledging cannabis’ relative safety compared to alcohol, and criticized the administration’s efforts to allow states to implement limited regulatory schemes for the retail production and sale of cannabis to adults. In public testimony, Leonhart refused to acknowledge whether she believed that crack cocaine, methamphetamine, or heroin posed greater risks to health than marijuana — instead opining, “All illegal drugs are bad.”

    Ms. Leonhart also actively opposed hemp law reform during her time as DEA director. She criticized a decision to fly a hempen flag over the Capitol, saying it was “her lowest point in 33 years in the DEA.” Last year, her agency unlawfully seized 250 pounds of legal hemp seeds destined for Kentucky’s state Agricultural Department.

    Always a true believer in the drug war no matter what the costs, in 2009 she described increased southern border violence as a sign of the “success” of her agency’s anti-drug strategies.

    Michele Leonhart is expected to leave the agency in mid-May.

  • by Paul Armentano, NORML Deputy Director April 7, 2015

    Marijuana cropsFor the second year in a row, federal officials are seeking to increase the supply of cannabis the government makes available for research protocols.

    DEA Administrator Michele Leonhart filed paperwork today announcing that the agency is seeking to increase its marijuana production quota for the year 2015 by nearly three-fold.

    Federal regulations permit a farm at the University of Mississippi to cultivate set quantities of cannabis for use in federally approved clinical trials. Regulators at the DEA, the US Food and Drug Administration, PHS (Public Health Service), and the US National Institute on Drug Abuse must approve any clinical protocol seeking to study the plant’s effects in human subjects.

    The agency says that the increased production is necessary because “research and product development involving cannabidiol is increasing beyond that previously anticipated.” The agency further acknowledges having received increased requests from NIDA “to provide for ongoing and anticipated research efforts involving marijuana.”

  • by Erik Altieri, NORML Communications Director May 30, 2014

    After a long debate that had the US House of Representatives in session until after midnight, the lower chamber of Congress cast a historic 219 to 189 vote to restrict the Department of Justice and the Drug Enforcement Administration from using taxpayer funds to interfere in state-sanctioned medical marijuana programs in the 20+ states that have enacted them.

    This measure was co-sponsored by Rep. Sam Farr (D-Calif.), Reps. Rohrabacher (R-Calf.), Don Young (R-Alaska), Earl Blumenauer (D-Ore.), Tom McClintock (R-Calif.), Steve Cohen (D-Tenn.), Paul Broun (R-Ga.), Jared Polis (D-Colo.), Steve Stockman (R-Texas), and Barbara Lee (D-Calif.). You can read the full text of the amendment here.

    170 Democrats and 49 Republicans voted in favor of the amendment, 172 Republicans and 17 Democrats voted against it. You can view the full vote breakdown here.

    “It would be hard to overstate the importance of tonight’s vote,” said NORML Communications Director Erik Altieri, “Approval of this amendment is a resounding victory for basic compassion and common sense.”

    Added NORML Deputy Director Paul Armentano, “This vote marks one of the first times since the passage of the Marihuana Tax Act of 1937 that a majority of the members of a chamber Congress have acted in a manner that significantly alters federal marijuana policy.”

    “The conflicting nature of state and federal marijuana laws has created an untenable situation,” co-sponsor Rep. Blumenauer said just before the House debate. “It’s time we take the federal government out of the equation so medical marijuana business owners operating under state law aren’t living in constant fear of having their doors kicked down in the middle of the night.”

    The House also approved amendments that prohibit the DOJ and DEA from using funds to interfere with state sanctioned industrial hemp cultivation.

    In February, members of Congress approved language (Section 7606) in the omnibus federal farm bill authorizing states to sponsor hemp research absent federal reclassification of the plant. Since then, five states — Hawaii, Indiana, Nebraska, Tennessee, and Utah — have enacted legislation authorizing state-sponsored hemp cultivation. (Similar legislation is pending in Illinois and South Carolina.) In total, more than a dozen states have enacted legislation redefining hemp as an agricultural commodity and allowing for state-sponsored research and/or cultivation of the crop

    These amendments were made to the 2015 Commerce, Justice, and Science Appropriations Bill, which now must be approved by the Senate and then signed by President Obama.

    NORML will keep you updated on this evolving situation.

  • by Paul Armentano, NORML Deputy Director May 23, 2014

    The Drug Enforcement Agency is permitting Kentucky farmers to go forward with plans to engage in the state-sponsored cultivation of industrial hemp.

    According to the Associated Press, representatives from the federal anti-drug agency late Thursday granted Kentucky regulators permission to import an estimated 250 pounds of hemp seeds.

    The agency had previously confiscated the seeds, which Kentucky officials had ordered from Italy. In response, Kentucky’s Agriculture Department sued the agency last week.

    After two federal hearings, as well as a face-to-face meeting with Senate Minority Leader Mitch McConnell (R-KY), DEA officials on agreed to authorize the shipment of hemp seeds to go forward — ending the approximately month-long standoff. Kentucky’s first modern hemp planting may occur as soon as this weekend, the Associated Press reports.

    In February, members of Congress approved language (Section 7606) in the omnibus federal farm bill authorizing states to sponsor hemp research absent federal reclassification of the plant. Since then, five states — Hawaii, Indiana, Nebraska, Tennessee, and Utah — have enacted legislation authorizing state-sponsored hemp cultivation. (Similar legislation is pending in Illinois and South Carolina.)

    Kentucky lawmakers initially approve legislation regulating hemp production in 2013.

    According to a 2013 white paper authored by the Congressional Research Service, a “commercial hemp industry in the United States could provide opportunities as an economically viable alternative crop for some US growers.”

  • by Paul Armentano, NORML Deputy Director May 20, 2014

    South Carolina lawmakers have approved legislation, Senate Bill 839, reclassifying varieties of cannabis possessing minute quantities of THC as an industrial crop rather than a controlled substance. The measure states, “It is lawful for an individual to cultivate, produce, or otherwise grow industrial hemp in this State to be used for any lawful purpose, including, but not limited to, the manufacture of industrial hemp products, and scientific, agricultural, or other research related to other lawful applications for industrial hemp.”

    Members of the Senate voted 42 to zero in favor of the bill. House members late last week also approved the measure by a vote of 72 to 28. Senate Bill 839 now awaits action by Republican Governor Nikki Haley.

    In February, members of Congress approved language (Section 7606) in the omnibus federal Farm Bill (aka the United States Agricultural Act of 2014) authorizing states to sponsor hemp research absent federal reclassification of the plant. Since that time, lawmakers in five states — Hawaii, Indiana, Nebraska, Tennessee, and Utah — have enacted legislation allowing for state-sponsored hemp cultivation.

    On Monday, Illinois Senate members unanimously approved similar legislation, House Bill 5085, in their state. Members of the House had previously voted 70 to 28 in favor of an earlier version of the bill. Once both chambers agree to concurrent language, the measure will go to the Governor’s desk.

    In total, more than a dozen states have enacted legislation redefining hemp as an agricultural commodity and allowing for state-sponsored research and/or cultivation of the crop.

    Last week, Kentucky state officials sued the US Drug Enforcement Administration after the agency refused to turn over a shipment of hemp seeds that were intended to be used as part of a state-approved research program. State officials designed the program to be compliant with Section 7606 of the federal farm bill. A federal hearing in the matter is scheduled for Wednesday, May 21.

    According to the U.S. Congressional Resource Service, the United States is the only developed nation that fails to cultivate industrial hemp as an economic crop.

Page 1 of 1612345...10...Last »
NORML 420 T-Shirt